Discontinued — last reported Q2 '22
CBRE Group Short-Term Borrowings increased by 16.1% to $2.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $2.78B to $2.86B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 12.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $668.75M | $682.40M | $906.00M | $2.78B | $2.79B | $2.71B | $2.47B | $2.86B |
| QoQ Change | — | -49.0% | +2.0% | +32.8% | +206.4% | +0.6% | -2.9% | -9.2% | +16.1% |
| YoY Change | — | -49.0% | +2.0% | +32.8% | — | — | — | +172.1% | +3.1% |